Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data Collection
NCT ID: NCT02281721
Last Updated: 2021-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
150 participants
OBSERVATIONAL
2015-03-18
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Feasibility Study of the Surpass Aneurysm-Embolization System in Intracranial Arteries
NCT01101347
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
NCT06174727
A Single-arm Trial of the Flow Diverter (Tonbridge) For Endovascular Treatment of Intracranial Aneurysms
NCT04918420
Safety and Efficacy of the Surpass Evolve Flow Diverter in Treating Intracranial Aneurysms
NCT06731946
Safety and Effectiveness of an Intracranial Aneurysm Embolization System for Treating Large or Giant Wide Neck Aneurysms
NCT01716117
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Group; Surpass Flow Diverter(s)
Individuals using the Surpass Flow Diverter(s)
Surpass Flow Diverter(s)
Endovascular placement of a Surpass Flow Diverter(s) for the treatment of an intracranial aneurysm(s)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surpass Flow Diverter(s)
Endovascular placement of a Surpass Flow Diverter(s) for the treatment of an intracranial aneurysm(s)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stryker Neurovascular
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick A Brouwer, MD
Role: PRINCIPAL_INVESTIGATOR
Karolinska Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AZ groeninge
Kortrijk, , Belgium
Helsinki University Hospital
Helsinki, , Finland
Turun yliopistollinen keskussairaala
Turku, , Finland
Hopital Jean Minjoz
Besançon, , France
APHP - Kremlin Bicêtre
Le Kremlin-Bicêtre, , France
Fondation Rothschild
Paris, , France
Hopital Bretonneau
Tours, , France
Freiburg University Hospital
Freiburg im Breisgau, , Germany
Klinikum Kassel
Kassel, , Germany
Universitätsmedizin Mannheim
Mannheim, , Germany
San Martino Hospital
Genova, , Italy
Neuroradiologia Azienda ILSS9
Treviso, , Italy
Radboudumc
Nijmegen, , Netherlands
Hospital Clinic de Barcelona
Barcelona, , Spain
Hospital Universitario Marques de Valdecilla
Santander, , Spain
Karolinska University Hospital in Solna, Department of Neuroradiology
Stockholm, , Sweden
Queen's Hospital of Romford, NHS Barking, Havering and Redbridge University Hospitals Trust
Romford, Essex, United Kingdom
Queen Elizabeth Hospital
Birmingham, , United Kingdom
The Walton center
Liverpool, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
T4029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.